-
VEMERIX Publishes Industry Report on the Global Shift to Disposable Circumcision Devices
Randomized data show single-use circumcision devices cut operative time roughly four-fold and blood loss about five-fold — an Asia-led device shift the US FDA record barely registers. WEIHAI, China, July 29, 2026 /PRNewswire/ — VEMERIX, the international medical-device brand of Weihai Medison Medical Equipment Co., Ltd., today published an industry report examining the global shift
-
Healthcare AI Leader Parminder Bhatia Joins Helio Genomics Board of Directors
IRVINE, Calif., July 16, 2026 /PRNewswire/ — Helio Genomics, Inc., a commercial-stage AI-powered precision liver diagnostics company focused on improving outcomes for at-risk patients through early cancer detection, disease surveillance, and biomarker-driven precision medicine, today announced the appointment of Parminder (Parry) Bhatia, Senior Vice President of Artificial Intelligence at Edwards Lifesciences, to its Board of
-
Sparkling Sciences Obtains International INCI Certification for iPSC Exosome
Completes Kyoto University Patent Licensing Agreement TAIPEI, June 23, 2026 /PRNewswire/ — Sparkling Sciences Co., Ltd., under TOMO YUME Group, announced it has obtained international INCI certification for iPSC Exosome and completed Kyoto University’s patent licensing agreement. INCI Name: Human Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cell Exosomes (INCI ID: 41693) Sparkling Sciences Obtains International INCI
-
Scientific Longevity Company Immorta Bio Appoints Former Ernst & Young Health Sciences Partner Howard Brooks to Corporate Board of Directors
Board expansion strengthens governance, strategic leadership, and capital markets engagement as Immorta Bio advances toward the clinic MIAMI, May 21, 2026 /PRNewswire/ — Immorta Bio Inc., a scientific longevity company focused on Treating Diseases of Aging and Treating Aging as Disease™, today announced the appointment of Howard Brooks, former Ernst & Young (EY) Health Sciences Partner, to its Corporate Board of Directors.
-
FirmTech Launches June “Orgasm-A-Day Challenge,”Giving $500 to the TechRing User Who Tracks the Most Erections
Men’s Health Month Contest Uses FirmTech’s Smart Sextech Wearable to Make Sexual Wellness More Measurable, Open, and Fun BOZEMAN, Mont., May 20, 2026 /PRNewswire/ — FirmTech, a sexual health and wellness wearable company focused on data-driven AI innovation, today announced the launch of its June “Orgasm-A-Day Challenge,” a contest that will award $500 to the
-
Symtech Solutions’ Digital Whiteboards Now Offer Smart Room Environment Control – Improving Patient Satisfaction and Reducing Hospital Costs
IVYLAND, Pa., May 19, 2026 /PRNewswire/ — Symtech Solutions has shifted the goal post for smart patient rooms by making it easier for patients to have control over their room’s environment. Symtech collaborated with Siemens to integrate room environmental controls into their Patient Digital Whiteboard and TV combo board. Giving patients control over their room
-
DoctorDerm Unveils Rebrand and Expands Platform with New Prescription Skin and Lash Treatments
SALT LAKE CITY, May 19, 2026 /PRNewswire/ — DoctorDerm today announced a comprehensive rebrand alongside the expansion of its personalized telehealth dermatology platform, introducing new prescription treatments designed to further its mission of making clinically guided skincare more accessible. The rebrand reflects a sharpened focus on simplicity, personalization, and provider-led care, making prescription dermatology a
-
TheWell Bioscience Launches Universal Xeno-Free Organoid Medium to Standardize Workflows and Reduce Costs
MONMOUTH JUNCTION, N.J., May 19, 2026 /PRNewswire/ — TheWell Bioscience, a biotechnology company pioneering advanced 3D cell culture technologies, today announced the launch of its RocketCell™ Organoid Xeno-Free Essential-Core Medium, a chemically defined, universal foundation medium designed to streamline organoid culture workflows while enhancing reproducibility, scalability, and cost efficiency. RocketCell™ Organoid Xeno-Free Essential-Core Medium As organoid
-
Brain-Body Therapy Pledges $100,000 to Fund Dr. Andrew Sherwood’s Research Project at Duke University
Gift deepens the scientific foundation of the app, whose model was informed by Dr. Sherwood’s decades of research on exercise and mental health LOS ANGELES, May 19, 2026 /PRNewswire/ — Brain-Body Therapy, (https://www.brain-bodytherapy.com/), a groundbreaking mental wellness app that combines clinically informed guidance with personalized movement, has confirmed a $100,000 gift in support of a research
-
Helio Genomics Announces Strategic Commercial Partnership with Syneos Health® to Accelerate Nationwide Adoption of HelioLiver™, A Breakthrough AI-Powered Blood Test for Early Liver Cancer Detection
Syneos Health’s proven commercialization expertise to engage healthcare providers and expand access to HelioLiver™ for high-risk patients in the United States IRVINE, Calif., May 19, 2026 /PRNewswire/ — Helio Genomics, a leading AI-powered TechBio company focused on revolutionizing early cancer detection, today announced a strategic commercial partnership with Syneos Health®, a leading fully integrated biopharmaceutical solutions
